Shares in UK-based clinical-stage biopharm PureTech Health have been given a boost by news that Roche has signed up to advance its exosome platform technology in a deal potentially worth more than $1 billion.
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.
Allergan, Molecular Partners’ abicipar has shown non-inferiority to Novartis’ Lucentis but with fewer injections in late-stage trials involving patients with neovascular age-related macular degeneration.
With just six weeks to go until the prestigious PharmaTimes Marketer of the Year closes for entry, marketers at all levels of their career are looking forward to taking part in the 25th anniversary celebrations.
The number of people taking part in NHS clinical research studies sponsored by the life sciences industry has risen dramatically over the last year, show new figures by the National Institute for Health Research (NIHR).